The U.S. Drug Enforcement Administration has\u00a0taken some cannabidiol off the most restrictive class\u00a0of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.<\/p>\n
It’s a decision that immediately affects CBD producers but also signals the agency\u2019s first admission that the plant has medical value.<\/p>\n
DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access<\/a> is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs<\/a><\/p>\n
The U.S. Drug Enforcement Administration has\u00a0taken some cannabidiol off the most restrictive class\u00a0of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval. It’s a decision that immediately affects CBD producers but also signals the agency\u2019s first admission that the plant hasContinue Reading<\/a><\/span><\/p>\n","protected":false},"author":123,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[136,848,3156,18,3157,2043,6008,10,195],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/29577"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/123"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=29577"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/29577\/revisions"}],"predecessor-version":[{"id":29578,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/29577\/revisions\/29578"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=29577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=29577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=29577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n
\nRead More: DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"